Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Ann Wojcicki's TTAM to Acquire 23andMe for $305M

Yahoo Finance on MSN · 7h
Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data
Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.
MedTech Dive · 8m
Anne Wojcicki wins bid to buy back 23andMe for $305M
A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.
CNN on MSN · 2d
Anne Wojcicki’s nonprofit wins bid to acquire genetic testing company 23andMe
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
1hon MSN
23andMe handed huge fine days after rescue
Testing firm 23andMe has been fined more than £2m for failing to protect the sensitive personal and genetic data of more than ...
1hon MSN
Regeneron is said to have declined a higher bid for 23andMe after Wojcicki's offer
Regeneron Pharmaceuticals (NASDAQ:REGN) has reportedly declined to submit a higher bid for 23andMe (OTC:MEHCQ) after a ...
1hon MSN
Anne Wojcicki's bid to buy back 23andMe may not end legal fight over DNA customer data
Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy